Crossmark

The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma

Crossref DOI link: https://doi.org/10.1007/s00432-016-2187-3

Published Online: 2016-06-18

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schaub, Christina

Schäfer, Niklas

Mack, Frederic

Stuplich, Moritz

Kebir, Sied

Niessen, Michael

Tzaridis, Theophilos

Banat, Mohammed

Vatter, Hartmut

Waha, Andreas

Herrlinger, Ulrich

Glas, Martin
License Information

License valid from 2016-06-18